Articles by James Calloway
IAG Shares Approach 52-Week Peak Ahead of Key Earnings Report
International Consolidated Airlines Group shares surged 4.3% on Friday, nearing a one-year high. Investors await the company's full-year results scheduled for February 27.
Compass Group Shares Dip Amid Office Sector Concerns Ahead of Strategy Update
Compass Group shares fell 2.5% to 2,125p, underperforming the FTSE 100, as investors remain cautious about office demand ahead of Monday's management briefing.
Diageo Shares Slip Ahead of Interim Results, Focus on Demand and Cost Strategy
Diageo shares declined 1.5% on Friday as investors await interim results on February 25. Attention is on demand trends in key markets and the company's updated financial guidance.
Standard Chartered Shares Gain Ahead of Key Results and Dividend Decision
Standard Chartered shares outperformed the FTSE 100, rising 1.87% to £18.82. Investors await the bank's full-year results and final dividend decision on February 24.
BAE Systems Awaits Key Results, Unveils Tech Incubator Amid Buyback Activity
BAE Systems shares rose ahead of full-year results due Feb. 18, with investors focused on 2026 guidance and shareholder returns. The firm also launched a dual-use tech incubator.
Barclays Gains Ahead of Key Earnings and Strategic Update
Barclays shares rose 2.71% to 479.1 pence on Friday, setting a positive tone before the bank's full-year results and strategic targets announcement on Tuesday. Investors are focused on cost management, credit quality, and capital returns.
Unilever Awaits Key Post-Demerger Results as Shares Hold Steady
Unilever shares closed flat at 5,250 pence ahead of its first full-year report since spinning off its ice cream division. Investors await clarity on 2026 sales growth and margin outlook.
Reckitt Announces £1.6 Billion Special Dividend Ahead of Key Investor Events
Reckitt Benckiser shares hold near 52-week highs as the company prepares to distribute a £1.6 billion special dividend on February 20, with management set to present at the CAGNY conference on February 19.
GSK Gains EU Approval for Nucala in COPD, Stock Momentum in Focus
GSK shares rose after EU regulators approved expanded use of Nucala for chronic obstructive pulmonary disease. The stock has surged 17% this week and nearly 49% over the past year.
British American Tobacco Gains Ahead of Earnings, Buyback Continues
British American Tobacco shares rose 1.2% to 4,609 pence Friday, outperforming the FTSE 100. Investors await preliminary results due February 12 for updates on nicotine alternatives and competitive positioning.
SSE Shares Approach Yearly High as Investors Eye Regulatory and Rate Decisions
SSE shares gained 1.21% to close at 2,510 pence, nearing a 52-week peak. The utility issued a 2025/26 EPS forecast of 144-152p and highlighted a 64% surge in network investment.
RELX Shares Extend Losses Amid AI Disruption Fears Ahead of Earnings
RELX shares fell 4.6% to 2,145p, nearing a 52-week low, as investors weigh AI's impact ahead of full-year results on February 12. The company continues its share buyback program.